publicações selecionadas
-
artigo de revista
- Neurotherapeutic effect of Hyptis spp. leaf extracts in Caenorhabditis elegans models of tauopathy and polyglutamine disease: Role of the glutathione redox cycle. Free Radical Biology and Medicine. 2021
- Data on the effects of Hyptis spp. and Lycium spp. plant extracts in C. elegans models of genetically determined neurodegenerative diseases. Data in Brief. 2020
- Sorting nexin 3 mutation impairs development and neuronal function in Caenorhabditis elegans. Cellular and Molecular Life Sciences. 2018
- Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease. Brain. 2015
- Using C-elegans to Decipher the Cellular and Molecular Mechanisms Underlying Neurodevelopmental Disorders. Molecular Neurobiology. 2013
-
documento
- A new lead compound for triple negative breast cancer therapy 2021
- Unravelling the anticancer potential of novel compounds for breast cancer therapy 2020
- New chromene derivatives: unravelling the molecular mechanisms for breast cancer treatment 2019
- Exploitation of novel chromene derivatives for breast cancer treatment 2019
- Exploitation of novel chromene derivatives for breast cancer treatment. 2019
- New chromene derivatives: Unraveling the molecular mechanisms for breast cancer therapy 2019
- New chromene derivatives: Unraveling the molecular mechanisms for breast cancer therapy. 2019
- In vitro and in vivo evaluation of new chromene derivatives as potent anticancer agents 2019
- In vitro and in vivo evaluation of new chromene derivatives as potent anticancer agents. 2019
- Neuroprotective and antioxidant effects of Maranta arundinacea and Porophyllum ruderale in Caenorhabditis elegans 2019